Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancerSang‐A Kim, Keun‐Wook Lee|Scientific Reports|2021Cited by 20